MetLife, Inc. Logo

MetLife, Inc.

MET

(2.2)
Stock Price

81,36 USD

0.44% ROA

12.9% ROE

20.34x PER

Market Cap.

58.323.066.000,00 USD

69.42% DER

2.56% Yield

5.27% NPM

MetLife, Inc. Stock Analysis

MetLife, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

MetLife, Inc. Fundamental Stock Analysis
# Analysis Rating
1 Dividend Growth

With a history of consistent dividend increases over the last five years, the company has proven to be a reliable choice for investors seeking steady income.

2 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

3 ROE

The stock's ROE falls within an average range (8.04%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (0.36%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 PBV

The stock's PBV ratio (1.83x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

6 DER

The stock has a reasonable amount of debt compared to its ownership (73%), suggesting a balanced financial position and a moderate level of risk.

7 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (1.460), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

8 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

10 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

11 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

MetLife, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

MetLife, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

MetLife, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

MetLife, Inc. Revenue
Year Revenue Growth
1995 1.177.000.000
1996 1.243.000.000 5.31%
1997 1.418.000.000 12.34%
1998 26.525.000.000 94.65%
1999 24.748.000.000 -7.18%
2000 31.947.000.000 22.53%
2001 31.928.000.000 -0.06%
2002 33.147.000.000 3.68%
2003 35.789.000.000 7.38%
2004 39.014.000.000 8.27%
2005 44.776.000.000 12.87%
2006 48.396.000.000 7.48%
2007 53.007.000.000 8.7%
2008 50.989.000.000 -3.96%
2009 41.058.000.000 -24.19%
2010 53.079.000.000 22.65%
2011 65.384.000.000 18.82%
2012 68.571.000.000 4.65%
2013 69.396.000.000 1.19%
2014 73.265.000.000 5.28%
2015 61.257.000.000 -19.6%
2016 60.732.000.000 -0.86%
2017 62.308.000.000 2.53%
2018 67.941.000.000 8.29%
2019 69.620.000.000 2.41%
2020 67.842.000.000 -2.62%
2021 71.080.000.000 4.56%
2022 69.898.000.000 -1.69%
2023 63.464.000.000 -10.14%
2023 66.407.000.000 4.43%
2024 71.292.000.000 6.85%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

MetLife, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1995 0
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

MetLife, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1995 1.786.000.000
1996 1.728.000.000 -3.36%
1997 4.765.000.000 63.74%
1998 0 0%
1999 0 0%
2000 0 0%
2001 2.459.000.000 100%
2002 2.499.000.000 1.6%
2003 2.685.000.000 6.93%
2004 2.874.000.000 6.58%
2005 3.163.000.000 9.14%
2006 3.430.000.000 7.78%
2007 3.556.000.000 3.54%
2008 4.026.000.000 11.67%
2009 4.283.000.000 6%
2010 5.375.000.000 20.32%
2011 7.773.000.000 30.85%
2012 8.076.000.000 3.75%
2013 7.426.000.000 -8.75%
2014 7.185.000.000 -3.35%
2015 7.177.000.000 -0.11%
2016 7.114.000.000 -0.89%
2017 6.724.000.000 -5.8%
2018 6.462.000.000 -4.05%
2019 6.554.000.000 1.4%
2020 5.775.000.000 -13.49%
2021 5.771.000.000 -0.07%
2022 5.891.000.000 2.04%
2023 0 0%
2023 6.177.000.000 100%
2024 5.920.000.000 -4.34%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

MetLife, Inc. EBITDA
Year EBITDA Growth
1995 1.106.000.000
1996 1.335.000.000 17.15%
1997 1.182.000.000 -12.94%
1998 1.399.000.000 15.51%
1999 790.000.000 -77.09%
2000 1.926.000.000 58.98%
2001 652.000.000 -195.4%
2002 2.051.000.000 68.21%
2003 3.860.000.000 46.87%
2004 4.678.000.000 17.49%
2005 6.985.000.000 33.03%
2006 8.085.000.000 13.61%
2007 7.192.000.000 -12.42%
2008 5.718.000.000 -25.78%
2009 -2.865.000.000 299.58%
2010 5.508.000.000 152.02%
2011 11.805.000.000 53.34%
2012 3.482.000.000 -239.03%
2013 6.027.000.000 42.23%
2014 10.703.000.000 43.69%
2015 9.359.000.000 -14.36%
2016 1.654.000.000 -465.84%
2017 4.464.000.000 62.95%
2018 8.052.000.000 44.56%
2019 5.573.000.000 -44.48%
2020 5.686.000.000 1.99%
2021 6.180.000.000 7.99%
2022 3.778.000.000 -63.58%
2023 -312.000.000 1310.9%
2023 2.361.000.000 113.21%
2024 4.780.000.000 50.61%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

MetLife, Inc. Gross Profit
Year Gross Profit Growth
1995 1.177.000.000
1996 1.243.000.000 5.31%
1997 1.418.000.000 12.34%
1998 26.525.000.000 94.65%
1999 24.748.000.000 -7.18%
2000 31.947.000.000 22.53%
2001 31.928.000.000 -0.06%
2002 33.147.000.000 3.68%
2003 35.789.000.000 7.38%
2004 39.014.000.000 8.27%
2005 44.776.000.000 12.87%
2006 48.396.000.000 7.48%
2007 53.007.000.000 8.7%
2008 50.989.000.000 -3.96%
2009 41.058.000.000 -24.19%
2010 53.079.000.000 22.65%
2011 65.384.000.000 18.82%
2012 68.571.000.000 4.65%
2013 69.396.000.000 1.19%
2014 73.265.000.000 5.28%
2015 61.257.000.000 -19.6%
2016 60.732.000.000 -0.86%
2017 62.308.000.000 2.53%
2018 67.941.000.000 8.29%
2019 69.620.000.000 2.41%
2020 67.842.000.000 -2.62%
2021 71.080.000.000 4.56%
2022 69.898.000.000 -1.69%
2023 63.464.000.000 -10.14%
2023 66.407.000.000 4.43%
2024 71.292.000.000 6.85%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

MetLife, Inc. Net Profit
Year Net Profit Growth
1995 699.000.000
1996 853.000.000 18.05%
1997 1.203.000.000 29.09%
1998 1.343.000.000 10.42%
1999 617.000.000 -117.67%
2000 953.000.000 35.26%
2001 473.000.000 -101.48%
2002 1.605.000.000 70.53%
2003 2.217.000.000 27.6%
2004 2.758.000.000 19.62%
2005 4.714.000.000 41.49%
2006 6.293.000.000 25.09%
2007 4.317.000.000 -45.77%
2008 3.209.000.000 -34.53%
2009 -2.246.000.000 242.88%
2010 4.014.000.000 155.95%
2011 6.423.000.000 37.51%
2012 5.808.000.000 -10.59%
2013 6.409.000.000 9.38%
2014 6.309.000.000 -1.59%
2015 5.373.000.000 -17.42%
2016 850.000.000 -532.12%
2017 4.010.000.000 78.8%
2018 5.123.000.000 21.73%
2019 5.899.000.000 13.15%
2020 5.407.000.000 -9.1%
2021 6.855.000.000 21.12%
2022 2.354.000.000 -191.21%
2023 1.956.000.000 -20.35%
2023 1.578.000.000 -23.95%
2024 3.784.000.000 58.3%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

MetLife, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1995 1
1996 1 100%
1997 2 0%
1998 2 0%
1999 1 0%
2000 2 100%
2001 1 0%
2002 2 100%
2003 3 33.33%
2004 4 0%
2005 6 50%
2006 8 25%
2007 6 -60%
2008 4 -25%
2009 -3 300%
2010 4 150%
2011 5 20%
2012 5 0%
2013 6 0%
2014 6 0%
2015 5 0%
2016 1 0%
2017 4 100%
2018 5 40%
2019 6 16.67%
2020 6 -20%
2021 7 28.57%
2022 3 -250%
2023 2 0%
2023 2 -100%
2024 5 80%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

MetLife, Inc. Free Cashflow
Year Free Cashflow Growth
1997 2.872.000.000
1998 842.000.000 -241.09%
1999 3.865.000.000 78.21%
2000 910.000.000 -324.73%
2001 4.799.000.000 81.04%
2002 4.997.000.000 3.96%
2003 7.363.000.000 32.13%
2004 8.066.000.000 8.72%
2005 8.005.000.000 -0.76%
2006 6.600.000.000 -21.29%
2007 1.187.000.000 -456.02%
2008 6.217.000.000 80.91%
2009 3.224.000.000 -92.83%
2010 5.165.000.000 37.58%
2011 9.016.000.000 42.71%
2012 18.158.000.000 50.35%
2013 12.699.000.000 -42.99%
2014 11.743.000.000 -8.14%
2015 8.572.000.000 -36.99%
2016 6.293.000.000 -36.21%
2017 7.721.000.000 18.5%
2018 4.669.000.000 -65.37%
2019 8.133.000.000 42.59%
2020 7.370.000.000 -10.35%
2021 16.956.000.000 56.53%
2022 13.204.000.000 -28.42%
2023 3.475.000.000 -279.97%
2023 12.551.000.000 72.31%
2024 3.490.000.000 -259.63%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

MetLife, Inc. Operating Cashflow
Year Operating Cashflow Growth
1997 2.872.000.000
1998 842.000.000 -241.09%
1999 3.865.000.000 78.21%
2000 1.326.000.000 -191.48%
2001 4.799.000.000 72.37%
2002 4.997.000.000 3.96%
2003 7.363.000.000 32.13%
2004 8.066.000.000 8.72%
2005 8.005.000.000 -0.76%
2006 6.600.000.000 -21.29%
2007 1.187.000.000 -456.02%
2008 10.703.000.000 88.91%
2009 3.803.000.000 -181.44%
2010 7.996.000.000 52.44%
2011 10.290.000.000 22.29%
2012 17.160.000.000 40.03%
2013 16.131.000.000 -6.38%
2014 16.376.000.000 1.5%
2015 14.129.000.000 -15.9%
2016 14.827.000.000 4.71%
2017 12.283.000.000 -20.71%
2018 11.738.000.000 -4.64%
2019 13.786.000.000 14.86%
2020 11.639.000.000 -18.45%
2021 12.596.000.000 7.6%
2022 13.204.000.000 4.6%
2023 3.475.000.000 -279.97%
2023 13.721.000.000 74.67%
2024 3.490.000.000 -293.15%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

MetLife, Inc. Capital Expenditure
Year Capital Expenditure Growth
1997 0
1998 0 0%
1999 0 0%
2000 416.000.000 100%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 4.486.000.000 100%
2009 579.000.000 -674.78%
2010 2.831.000.000 79.55%
2011 1.274.000.000 -122.21%
2012 -998.000.000 227.66%
2013 3.432.000.000 129.08%
2014 4.633.000.000 25.92%
2015 5.557.000.000 16.63%
2016 8.534.000.000 34.88%
2017 4.562.000.000 -87.07%
2018 7.069.000.000 35.46%
2019 5.653.000.000 -25.05%
2020 4.269.000.000 -32.42%
2021 -4.360.000.000 197.91%
2022 0 0%
2023 0 0%
2023 1.170.000.000 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

MetLife, Inc. Equity
Year Equity Growth
1998 14.867.000.000
1999 13.690.000.000 -8.6%
2000 17.479.000.000 21.68%
2001 17.318.000.000 -0.93%
2002 18.650.000.000 7.14%
2003 21.149.000.000 11.82%
2004 22.824.000.000 7.34%
2005 29.101.000.000 21.57%
2006 33.798.000.000 13.9%
2007 35.179.000.000 3.93%
2008 23.734.000.000 -48.22%
2009 33.498.000.000 29.15%
2010 48.996.000.000 31.63%
2011 60.276.000.000 18.71%
2012 64.958.000.000 7.21%
2013 62.983.000.000 -3.14%
2014 72.659.000.000 13.32%
2015 68.496.000.000 -6.08%
2016 67.480.000.000 -1.51%
2017 58.870.000.000 -14.63%
2018 52.958.000.000 -11.16%
2019 66.382.000.000 20.22%
2020 74.817.000.000 11.27%
2021 67.749.000.000 -10.43%
2022 27.287.000.000 -148.28%
2023 25.895.000.000 -5.38%
2023 30.253.000.000 14.41%
2024 27.540.000.000 -9.85%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

MetLife, Inc. Assets
Year Assets Growth
1998 215.346.000.000
1999 225.232.000.000 4.39%
2000 255.018.000.000 11.68%
2001 256.898.000.000 0.73%
2002 277.385.000.000 7.39%
2003 326.841.000.000 15.13%
2004 356.808.000.000 8.4%
2005 481.645.000.000 25.92%
2006 527.715.000.000 8.73%
2007 558.562.000.000 5.52%
2008 501.678.000.000 -11.34%
2009 539.314.000.000 6.98%
2010 730.705.000.000 26.19%
2011 799.625.000.000 8.62%
2012 836.781.000.000 4.44%
2013 885.296.000.000 5.48%
2014 902.337.000.000 1.89%
2015 877.933.000.000 -2.78%
2016 898.764.000.000 2.32%
2017 719.892.000.000 -24.85%
2018 687.538.000.000 -4.71%
2019 740.463.000.000 7.15%
2020 795.146.000.000 6.88%
2021 759.708.000.000 -4.66%
2022 666.611.000.000 -13.97%
2023 652.120.000.000 -2.22%
2023 687.584.000.000 5.16%
2024 675.745.000.000 -1.75%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

MetLife, Inc. Liabilities
Year Liabilities Growth
1998 200.479.000.000
1999 211.542.000.000 5.23%
2000 237.539.000.000 10.94%
2001 239.580.000.000 0.85%
2002 258.735.000.000 7.4%
2003 305.692.000.000 15.36%
2004 333.984.000.000 8.47%
2005 452.544.000.000 26.2%
2006 493.917.000.000 8.38%
2007 523.383.000.000 5.63%
2008 477.944.000.000 -9.51%
2009 505.816.000.000 5.51%
2010 681.709.000.000 25.8%
2011 739.349.000.000 7.8%
2012 771.823.000.000 4.21%
2013 822.313.000.000 6.14%
2014 829.678.000.000 0.89%
2015 809.437.000.000 -2.5%
2016 831.284.000.000 2.63%
2017 661.022.000.000 -25.76%
2018 634.580.000.000 -4.17%
2019 674.081.000.000 5.86%
2020 720.329.000.000 6.42%
2021 691.959.000.000 -4.1%
2022 639.324.000.000 -8.23%
2023 626.225.000.000 -2.09%
2023 657.331.000.000 4.73%
2024 648.205.000.000 -1.41%

MetLife, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
96.8
Net Income per Share
4.09
Price to Earning Ratio
20.34x
Price To Sales Ratio
0.85x
POCF Ratio
4.09
PFCF Ratio
4.02
Price to Book Ratio
2.17
EV to Sales
0.82
EV Over EBITDA
19.06
EV to Operating CashFlow
3.9
EV to FreeCashFlow
3.89
Earnings Yield
0.05
FreeCashFlow Yield
0.25
Market Cap
58,32 Bil.
Enterprise Value
56,45 Bil.
Graham Number
59.44
Graham NetNet
-1062.99

Income Statement Metrics

Net Income per Share
4.09
Income Quality
4.98
ROE
0.1
Return On Assets
0.01
Return On Capital Employed
0.01
Net Income per EBT
0.73
EBT Per Ebit
0.98
Ebit per Revenue
0.07
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.09
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
1
Operating Profit Margin
0.07
Pretax Profit Margin
0.07
Net Profit Margin
0.05

Dividends

Dividend Yield
0.03
Dividend Yield %
2.56
Payout Ratio
0.6
Dividend Per Share
2.13

Operating Metrics

Operating Cashflow per Share
20.37
Free CashFlow per Share
20.43
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0.06
Return on Invested Capital
0.05
Return on Tangible Assets
0
Days Sales Outstanding
170.72
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
2.14
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0.06

Balance Sheet

Cash per Share
50,77
Book Value per Share
38,76
Tangible Book Value per Share
26.16
Shareholders Equity per Share
38.36
Interest Debt per Share
28.11
Debt to Equity
0.69
Debt to Assets
0.03
Net Debt to EBITDA
-0.63
Current Ratio
3.97
Tangible Asset Value
18,59 Bil.
Net Current Asset Value
-576,31 Bil.
Invested Capital
472374000000
Working Capital
53,79 Bil.
Intangibles to Total Assets
0.01
Average Receivables
31,08 Bil.
Average Payables
0,00 Bil.
Average Inventory
-333806500000
Debt to Market Cap
0.32

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

MetLife, Inc. Dividends
Year Dividends Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 1 0%
2006 1 0%
2007 1 0%
2008 1 0%
2009 1 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 100%
2014 1 0%
2015 1 0%
2016 2 0%
2017 2 0%
2018 2 0%
2019 2 0%
2020 2 0%
2021 2 0%
2022 2 0%
2023 2 50%
2024 2 -100%

MetLife, Inc. Profile

About MetLife, Inc.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

CEO
Mr. Michel Abbas Khalaf
Employee
45.000
Address
200 Park Avenue
New York, 10166-0188

MetLife, Inc. Executives & BODs

MetLife, Inc. Executives & BODs
# Name Age
1 Ms. Marlene Beverly Debel B.S., M.B.A.
Executive Vice President, Chief Risk Officer & Head of Insurance Investments
70
2 Mr. Pawan Singh Verma
Executive Vice President & Chief Information Officer
70
3 Ms. Shurawl Sibblies
Executive Vice President & Chief Human Resources Officer
70
4 Mr. Michael Kevin Farrell
EVice President, Head - Independent Distribution - St Louis-Based GenAmerica Financial & MetLife Investors Group
70
5 Mr. Ramy Tadros
President of U.S. Business & Head of MetLife Holdings
70
6 Mr. Michel Abbas Khalaf
Chief Executive Officer, President & Director
70
7 Ms. Monica M. Curtis
Executive Vice President & Chief Legal Officer
70
8 Mr. John Arthur Hall
Senior Vice President & Head of Investor Relations
70
9 Mr. Michael Roberts
Executive Vice President & Chief Marketing Officer
70
10 Mr. Bill Pappas
Executive Vice President and Head of Global Technology & Operations
70

MetLife, Inc. Competitors